LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research


Modulating RNA Function by Targeting Regulatory Proteins

Intensive research over the past decade has revealed that non-coding RNAs have critical regulatory roles in nearly all biological processes.  The diverse functions of ncRNAs are in turn regulated by specific binding proteins and processing enzymes.  Twentyeight-Seven is building on these discoveries and developing small-molecule drugs that target RNA regulatory proteins, and modulate the function of specific ncRNAs that have causative roles in human disease.

Twentyeight-Seven logo
Website - Coming Soon
  • Kazumi Shiosaki, PhD Acting Chief Executive Officer
  • Ross Stein, PhD Chief Scientific Officer
  • Reid Leonard, PhD Acting Chief Business Officer
  • Andy Snyder, PhD Principal Scientist & Head of Cell Biology
  • David Wilson Principal Scientist & Head of Biochemistry